Spots Global Cancer Trial Database for ovarian neoplasm
Every month we try and update this database with for ovarian neoplasm cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| A Multi-Institutional Phase II Study of Cyclophosphamide, Paclitaxel, Cisplatin With G-CSF for Patients With Newly Diagnosed Advanced Stage Ovarian Cancer | NCT00001426 | Ovarian Neoplas... | Cyclophosphamid... Paclitaxel Cisplatin G-CSF | - | National Institutes of Health Clinical Center (CC) | |
| Supportive Programs for Supporting Optimal Recovery in Participants Undergoing Gynecological Surgery | NCT03681405 | Ovarian Neoplas... Uterine Neoplas... | Informational I... Questionnaire A... Telephone-Based... | 18 Years - | Wake Forest University Health Sciences | |
| Sorafenib and Bevacizumab to Treat Ovarian, Fallopian and Peritoneal Cancer | NCT00436215 | Ovarian Neoplas... Fallopian Tube ... Primary Periton... | Bevacizumab BAY 43-9006 | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Phase II CT-2103/Carboplatin in Ovarian Cancer | NCT00069901 | Ovarian Neoplas... | CT-2103 (poly(L... carboplatin | 18 Years - | CTI BioPharma | |
| Minimally Invasive Robotic Surgery, Role in Optimal Debulking Ovarian Cancer, Recovery & Survival | NCT04402333 | Ovarian Cancer Ovarian Neoplas... Ovarian Neoplas... Fallopian Tube ... Peritoneal Canc... | Robotic Interva... | 18 Years - | Royal Surrey County Hospital NHS Foundation Trust | |
| Study BT8009-100 in Subjects With Nectin-4 Expressing Advanced Malignancies | NCT04561362 | Advanced Solid ... Urinary Bladder... Triple Negative... Carcinoma, Non-... Ovarian Neoplas... | BT8009 Pembrolizumab | 18 Years - | BicycleTx Limited | |
| Trabectedin/Caelyx vs Cisplatin Hypersensitivity in Relapsed Ovarian Cancer Patients Allergic to Platinum | NCT05512676 | Ovarian Neoplas... Chemotherapeuti... Chemotherapy Ef... Chemotherapy-in... Chemotherapy-in... | 18 Years - 80 Years | Oslo University Hospital | ||
| Phase II CT-2103/Carboplatin in Ovarian Cancer | NCT00069901 | Ovarian Neoplas... | CT-2103 (poly(L... carboplatin | 18 Years - | CTI BioPharma | |
| Personalized Patient Derived Xenograft (pPDX) Modeling to Test Drug Response in Matching Host | NCT02732860 | Colorectal Neop... Colorectal Canc... Breast Cancer Breast Neoplasm... Ovarian Cancer Ovarian Neoplas... | Molecular Profi... | 18 Years - | University Health Network, Toronto | |
| Feasibility Study of a 4 Stage Bowel Obstruction Cancer Diet | NCT04898842 | Colorectal Canc... Colorectal Neop... Colorectal Carc... Colorectal Aden... Colorectal Canc... Ovarian Cancer Ovarian Neoplas... Metastatic Colo... Metastatic Ovar... Peritoneal Carc... Bowel Obstructi... | Dietary interve... | 18 Years - | Royal Surrey County Hospital NHS Foundation Trust | |
| p53 Vaccine for Ovarian Cancer | NCT00001827 | Ovarian Neoplas... | aldesleukin incomplete Freu... p53 peptide vac... sargramostim therapeutic aut... in vitro-treate... | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Safety and Tolerability Study of TAK-165 in Subjects With Tumors Expressing HER2 | NCT00034281 | Breast Neoplasm Pancreatic Neop... Lung Neoplasm Ovarian Neoplas... Renal Neoplasm | TAK-165 | 18 Years - | Takeda | |
| Study to Evaluate the Safety and Efficacy of TSR-042, Bevacizumab, and Niraparib in Participants With Recurrent Ovarian Cancer | NCT05751629 | Ovarian Neoplas... | Dostarlimab Bevacizumab Niraparib | 18 Years - | Tesaro, Inc. | |
| Safety and Tolerability Study of TAK-165 in Subjects With Tumors Expressing HER2 | NCT00034281 | Breast Neoplasm Pancreatic Neop... Lung Neoplasm Ovarian Neoplas... Renal Neoplasm | TAK-165 | 18 Years - | Takeda | |
| Comparison of US Bilateral Erector Spinae Plane Block, US Bilateral Quadratus Lumborum Block and Lumbar Epidural for Postoperative Analgesia in Patients Undergoing Total Abdominal Hysterectomy | NCT06397300 | Comparison of U... | bilateral Ultra... quadratus lumbo... lumbar epidural | 18 Years - 65 Years | National Cancer Institute, Egypt | |
| Evaluation of Ocoxin-Viusid® in Advanced or Metastatic Ovarian Epithelial Cancer | NCT03562897 | Carcinoma Ovarian Neoplas... Endocrine Gland... Urogenital Neop... Ovarian Disease... Adnexal Disease... Genital Disease... Female Urogenit... Female Urogenit... Endocrine Syste... Gonadal Disorde... Genital Neoplas... Neoplasms, Glan... | Ocoxin-Viusid | 18 Years - | Catalysis SL | |
| Folate Receptor in Diagnosing Ovarian Cancer Using Serum Samples From Patients With Newly Diagnosed Pelvic Mass or Previously Diagnosed Ovarian Cancer | NCT02520115 | Adnexal Mass Borderline Ovar... Ovarian Clear C... Ovarian Endomet... Ovarian Neoplas... Ovarian Serous ... Recurrent Ovari... | Dexamethasone Laboratory Biom... Valproic Acid | 18 Years - | Barbara Ann Karmanos Cancer Institute | |
| A Multi-center Study of VAL-083 in Patients With Recurrent Platinum Resistant Ovarian Cancer | NCT03281681 | Ovarian Cancer | VAL-083, Dianhy... | 18 Years - | Kintara Therapeutics, Inc. | |
| Study to Evaluate the Safety and Efficacy of TSR-042, Bevacizumab, and Niraparib in Participants With Recurrent Ovarian Cancer | NCT05751629 | Ovarian Neoplas... | Dostarlimab Bevacizumab Niraparib | 18 Years - | Tesaro, Inc. | |
| Study of the Effect of Intravenous AVE0005 (VEGF Trap) in Advanced Ovarian Cancer Patients With Recurrent Symptomatic Malignant Ascites | NCT00327444 | Ovarian Neoplas... Ascites | aflibercept (zi... Placebo aflibercept (zi... | 18 Years - | Sanofi | |
| NUC-1031 in Patients With Platinum-Resistant Ovarian Cancer | NCT03146663 | Ovarian Cancer | NUC-1031 500 mg NUC-1031 750mg | 18 Years - | NuCana plc | |
| Olaparib Real-world Utilization and Clinical Outcomes in France, Italy, and the UK | NCT04532645 | Ovary Cancer | Olaparib | 18 Years - | AstraZeneca | |
| Evaluation of Ocoxin-Viusid® in Advanced or Metastatic Ovarian Epithelial Cancer | NCT03562897 | Carcinoma Ovarian Neoplas... Endocrine Gland... Urogenital Neop... Ovarian Disease... Adnexal Disease... Genital Disease... Female Urogenit... Female Urogenit... Endocrine Syste... Gonadal Disorde... Genital Neoplas... Neoplasms, Glan... | Ocoxin-Viusid | 18 Years - | Catalysis SL | |
| Body Warming in Improving Blood Flow and Oxygen Delivery to Tumors in Patients With Cancer | NCT01896778 | Adult Liver Car... Breast Carcinom... Colon Carcinoma Kidney Neoplasm Lung Carcinoma Malignant Head ... Malignant Neopl... Melanoma Ovarian Neoplas... Soft Tissue Sar... | Hyperthermia Tr... Laboratory Biom... | 18 Years - | Roswell Park Cancer Institute | |
| Incidence of Cancer in Women at Increased Genetic Risk of Ovarian Cancer | NCT01139957 | Breast Carcinom... Fallopian Tube ... Ovarian Neoplas... Primary Periton... | Evaluation of C... Quality-of-Life... Questionnaire A... Study of High R... | 30 Years - | GOG Foundation | |
| Supportive Programs for Supporting Optimal Recovery in Participants Undergoing Gynecological Surgery | NCT03681405 | Ovarian Neoplas... Uterine Neoplas... | Informational I... Questionnaire A... Telephone-Based... | 18 Years - | Wake Forest University Health Sciences | |
| Efficacy and Safety of Involving Field Radiotherapy in the Oligo-lesions(Metastasis/Recurrent/Refractory) of Ovarian Cancer | NCT05059782 | Ovarian Cancer Neoplasm, Ovari... Ovarian Neoplas... Ovary Neoplasms Neoplasm, Ovary Neoplasms, Ovar... Ovary Neoplasm Neoplasms, Ovar... Ovary Cancer Cancer, Ovarian... Cancers, Ovary Ovary Cancers Cancer, Ovarian Cancers, Ovaria... Ovarian Cancers Cancer of Ovary Cancer of the O... | chemotherapy, t... IFRT, IMRT or S... | 18 Years - | Health Science Center of Xi'an Jiaotong University | |
| Prediction of Ovarian Malignancy in the Presence of Sonographic Pelvic Mass | NCT01477788 | Ovarian Neoplas... | - | HaEmek Medical Center, Israel | ||
| A Multi-center Study of VAL-083 in Patients With Recurrent Platinum Resistant Ovarian Cancer | NCT03281681 | Ovarian Cancer | VAL-083, Dianhy... | 18 Years - | Kintara Therapeutics, Inc. | |
| Cognitive-Behavioral Intervention for Worry, Uncertainty, and Insomnia for Cancer Survivors | NCT01929720 | Anxiety Disorde... Worry Uncertainty Sleep Disorders Insomnia Fatigue Pain Depression Cognitive-behav... Psychological I... Esophageal Canc... Pancreatic Canc... Leukemia Lung Cancer Multiple Myelom... Ovarian Neoplas... Stage III or IV... Stage IIIB, III... Glioblastoma Mu... Relapsed Lympho... Stage III or IV... Stage IIIC or I... | Cognitive-behav... | 18 Years - | Ohio State University Comprehensive Cancer Center | |
| Fluid Balance During Surgery for Ovarian Cancer | NCT03006939 | Ovarian Neoplas... Fluid Therapy | Cytoreductive s... | 18 Years - | University Hospital, Bonn | |
| Survivorship Care for Women Living With Ovarian Cancer: (POSTCARE-O) | NCT05752448 | Ovarian Neoplas... Depressive Symp... Quality of Life | POSTCare Surviv... | 18 Years - | Baylor College of Medicine | |
| Microarray Analysis for Human Genetic Disease | NCT00001898 | Breast Neoplasm Hereditary Neop... Melanoma Ovarian Neoplas... | - | National Institutes of Health Clinical Center (CC) | ||
| HORIZONS: Understanding the Impact of Cancer Diagnosis and Treatment on Everyday Life | NCT03000192 | Breast Cancer F... Breast Neoplasm Non-Hodgkin's B... Non-Hodgkin's L... NonHodgkin Lymp... Diffuse Large B... Diffuse Large C... Ovarian Cancer Ovarian Neoplas... Endometrial Can... Endometrial Neo... Cervical Cancer Cervical Neopla... Primary Periton... Fallopian Tube ... Fallopian Tube ... Vulvar Cancer Vulvar Neoplasm... | 16 Years - | University Hospital Southampton NHS Foundation Trust | ||
| MIRRORS-RCT Pilot: Role of Robotic Interval Cytoreductive Surgery for Advanced Ovarian Cancer | NCT05960630 | Ovarian Cancer Ovarian Neoplas... Ovarian Neoplas... Fallopian Tube ... Fallopian Tube ... Peritoneal Canc... | MIRRORS Protoco... Standard Open C... | 18 Years - | Royal Surrey County Hospital NHS Foundation Trust | |
| Study BT8009-100 in Subjects With Nectin-4 Expressing Advanced Malignancies | NCT04561362 | Advanced Solid ... Urinary Bladder... Triple Negative... Carcinoma, Non-... Ovarian Neoplas... | BT8009 Pembrolizumab | 18 Years - | BicycleTx Limited | |
| Study to Assess the Efficacy and Safety of a PARP Inhibitor for the Treatment of BRCA-positive Advanced Ovarian Cancer | NCT00494442 | Ovarian Neoplas... | KU-0059436 (AZD... KU-0059436 (AZD... | 18 Years - 130 Years | AstraZeneca | |
| Fluid Balance During Surgery for Ovarian Cancer | NCT03006939 | Ovarian Neoplas... Fluid Therapy | Cytoreductive s... | 18 Years - | University Hospital, Bonn | |
| Feasibility Study of a 4 Stage Bowel Obstruction Cancer Diet | NCT04898842 | Colorectal Canc... Colorectal Neop... Colorectal Carc... Colorectal Aden... Colorectal Canc... Ovarian Cancer Ovarian Neoplas... Metastatic Colo... Metastatic Ovar... Peritoneal Carc... Bowel Obstructi... | Dietary interve... | 18 Years - | Royal Surrey County Hospital NHS Foundation Trust | |
| EHealth Mindful Movement and Breathing in Improving Outcomes in Participants Undergoing Gynecologic Surgery | NCT03379376 | Female Reproduc... Malignant Femal... Malignant Uteri... Ovarian Carcino... Ovarian Neoplas... Suspicious for ... Uterine Neoplas... | Questionnaire A... Supportive Care | 18 Years - | Wake Forest University Health Sciences | |
| [18F]Fluciclatide-PET, Pazopanib and Paclitaxel in Ovarian Cancer | NCT01608009 | Ovarian Neoplas... | Pazopanib and p... | 18 Years - | Imperial College London | |
| DOXIL for Consolidation Therapy in Ovarian Cancer. | NCT00248248 | Ovarian Neoplas... | liposomal doxor... | 18 Years - | Southeastern Gynecologic Oncology | |
| A Multi-center Study of VAL-083 in Patients With Recurrent Platinum Resistant Ovarian Cancer | NCT03281681 | Ovarian Cancer | VAL-083, Dianhy... | 18 Years - | Kintara Therapeutics, Inc. | |
| MIRRORS-RCT Pilot: Role of Robotic Interval Cytoreductive Surgery for Advanced Ovarian Cancer | NCT05960630 | Ovarian Cancer Ovarian Neoplas... Ovarian Neoplas... Fallopian Tube ... Fallopian Tube ... Peritoneal Canc... | MIRRORS Protoco... Standard Open C... | 18 Years - | Royal Surrey County Hospital NHS Foundation Trust | |
| Veliparib With Carboplatin and Paclitaxel and as Continuation Maintenance Therapy in Adults With Newly Diagnosed Stage III or IV, High-grade Serous, Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer | NCT02470585 | Ovarian Cancer Ovarian Neoplas... | Veliparib Paclitaxel Carboplatin Placebo to Veli... | 18 Years - | AbbVie | |
| A Multi-center Study of VAL-083 in Patients With Recurrent Platinum Resistant Ovarian Cancer | NCT03281681 | Ovarian Cancer | VAL-083, Dianhy... | 18 Years - | Kintara Therapeutics, Inc. | |
| Study of the Effect of Intravenous AVE0005 (VEGF Trap) in Advanced Ovarian Cancer Patients With Recurrent Symptomatic Malignant Ascites | NCT00327444 | Ovarian Neoplas... Ascites | aflibercept (zi... Placebo aflibercept (zi... | 18 Years - | Sanofi | |
| Family Communication of Hereditary Breast and Ovarian Cancer Risk Among African Americans | NCT01374685 | Ovarian Neoplas... Cancer Genetics Breast Cancer | 18 Years - | National Institutes of Health Clinical Center (CC) | ||
| Study to Evaluate the Safety and Efficacy of TSR-042, Bevacizumab, and Niraparib in Participants With Recurrent Ovarian Cancer | NCT05751629 | Ovarian Neoplas... | Dostarlimab Bevacizumab Niraparib | 18 Years - | Tesaro, Inc. | |
| Minimally Invasive Robotic Surgery, Role in Optimal Debulking Ovarian Cancer, Recovery & Survival | NCT04402333 | Ovarian Cancer Ovarian Neoplas... Ovarian Neoplas... Fallopian Tube ... Peritoneal Canc... | Robotic Interva... | 18 Years - | Royal Surrey County Hospital NHS Foundation Trust | |
| Study to Assess the Efficacy and Safety of a PARP Inhibitor for the Treatment of BRCA-positive Advanced Ovarian Cancer | NCT00494442 | Ovarian Neoplas... | KU-0059436 (AZD... KU-0059436 (AZD... | 18 Years - 130 Years | AstraZeneca |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
